These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 26314375

  • 1. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I, Godsell J, Nold-Petry CA, Harris J, Hoi A, Morand EF, Nold MF.
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [Abstract] [Full Text] [Related]

  • 2. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 3. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS.
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [Abstract] [Full Text] [Related]

  • 4. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF.
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [Abstract] [Full Text] [Related]

  • 5. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y.
    Arthritis Res Ther; 2011 Jun 16; 13(3):R88. PubMed ID: 21679442
    [Abstract] [Full Text] [Related]

  • 6. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
    Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F, Morand EF.
    Lupus; 2018 Nov 16; 27(13):2029-2040. PubMed ID: 30301439
    [Abstract] [Full Text] [Related]

  • 7. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A.
    Przegl Lek; 2005 Nov 16; 62(9):838-42. PubMed ID: 16541713
    [Abstract] [Full Text] [Related]

  • 8. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein.
    Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM.
    J Autoimmun; 2010 Mar 16; 34(2):121-6. PubMed ID: 19699611
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D, Liu M, Liu B.
    Tohoku J Exp Med; 2018 Apr 16; 244(4):263-270. PubMed ID: 29576585
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y, Wang R, Liu S, Liu J, Pan W, Li F, Li J, Meng D.
    Int Immunopharmacol; 2019 Sep 16; 74():105680. PubMed ID: 31200339
    [Abstract] [Full Text] [Related]

  • 11. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA.
    Cytokine; 2015 Apr 16; 72(2):146-53. PubMed ID: 25647269
    [Abstract] [Full Text] [Related]

  • 12. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
    Lit LC, Wong CK, Tam LS, Li EK, Lam CW.
    Ann Rheum Dis; 2006 Feb 16; 65(2):209-15. PubMed ID: 15975968
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
    Mende R, Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi AY, Morand EF, Harris J, Lang T.
    Front Immunol; 2018 Feb 16; 9():1250. PubMed ID: 29930551
    [Abstract] [Full Text] [Related]

  • 14. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 15. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Liu C, Chen X, Jin Y, Qu R, Jiang PF, Wen GM, Tang ZH.
    Clin Exp Dermatol; 2007 Nov 03; 32(6):650-3. PubMed ID: 17725664
    [Abstract] [Full Text] [Related]

  • 16. Clinical associations of serum interleukin-17 in systemic lupus erythematosus.
    Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF.
    Arthritis Res Ther; 2013 Aug 23; 15(4):R97. PubMed ID: 23968496
    [Abstract] [Full Text] [Related]

  • 17. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov 23; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 18. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
    Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, Du J, Huang Z.
    J Transl Med; 2014 Mar 16; 12():69. PubMed ID: 24629023
    [Abstract] [Full Text] [Related]

  • 19. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Mar 16; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 20. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U, García-Iglesias T, Bucala R, Estrada-García I, González-López L, Cerpa-Cruz S, Parra-Rojas I, Gámez-Nava JI, Pérez-Guerrero EE, Muñoz-Valle JF.
    Cell Immunol; 2018 Feb 16; 324():42-49. PubMed ID: 29397904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.